Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pathophysiol. May 15, 2014; 5(2): 71-81
Published online May 15, 2014. doi: 10.4291/wjgp.v5.i2.71
Published online May 15, 2014. doi: 10.4291/wjgp.v5.i2.71
Category | Criteria |
Histology | One of the following: |
Periductal lymphoplasmacytic infiltrate with obliterative phlebitis and storiform fibrosis (LPSP) | |
Lymphoplasmacytic infiltrate with storiform fibrosis showing abundant IgG4 positive cells (> 10 cells/HPF) | |
Imaging (CT)/(MRI) | Typical; diffusely enlarged gland with diffuse rim enhancement, diffusely irregular attenuated pancreatic duct |
Other; focal pancreatic mass or enlargement; focal pancreatic duct stricture; pancreatic duct stricture, pancreatic atrophy; pancreatic calcification or pancreatitis | |
Serology | Elevated serum IgG4 level |
Other organ involvement | Hilar/intrahepatic biliary strictures, persistent distal biliary strictures, parotid or lacrimal gland involvement, mediastinal lymphadenopathy or retroperitoneal fibrosis |
Response to steroid therapy | Resolution/Marked improvement of pancreatic or extrapancreatic manifestion with steroid therapy |
- Citation: O’Reilly DA, Malde DJ, Duncan T, Rao M, Filobbos R. Review of the diagnosis, classification and management of autoimmune pancreatitis. World J Gastrointest Pathophysiol 2014; 5(2): 71-81
- URL: https://www.wjgnet.com/2150-5330/full/v5/i2/71.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v5.i2.71